Target ALS 2023 Annual Report
January 6, 2024 Tammy Sutherns

Over the past decade, Target ALS has ushered in a transformative era in ALS research, championing collaboration and driving innovation to make significant strides toward effective treatments for those living with ALS. While we take pride in the progress we’ve made, we are more determined than ever to elevate our efforts as we step into the next phase of our journey.
Related News
Q1 2026 Publications from our Innovation Ecosystem
March 31, 2026
Q1 2026 Research we Enable Update
March 31, 2026
Q1 2026 Grants & Funding Opportunities Update
March 31, 2026